Banner US IN.PACT Admiral Drug Coated Balloon

IN.PACT Admiral DCB Virtual Reality Experience

“It's exciting to have a non-stented option, because it's cheaper and safer. You guys had already done a great job with the presentation describing this. This just made it that much more exciting. Great demo.”

– Dr. James Harrell, Cardiovascular Surgeon, Covenant Medical Center


DCB Virtual Reality Reactions at Medtronic DCB Virtual Reality Reactions at Medtronic

View Gallery

The IN.PACT Admiral Drug-Coated Balloon received FDA Approval in the US in January 2015 and received the CE mark in Europe in 2009. Now, patients around the world suffering from peripheral artery disease (PAD) can be treated with the most clinically-effective device available on the market for the treatment of SFA disease.

While you wait to try the virtual reality experience yourself, learn more about the product and how it works by watching our video demo below or downloading our brochures.

To see the leading DCB in virtual reality, find us at an upcoming event or request an on-site demo at your organization.*

IN.PACT Admiral DCB Product Demo Mechanism of Action (Short)

For a list of DCB and Virtual Reality FAQs, download this PDF >>

Check back often for ongoing demo updates and device-related news!

* Supplies limited.


Where to Find Us Next


In The Press

  1. thumbnail Kansas City FOX 4 News (WDAF): New treatment for relief of leg pain

    March 18, 2015

  2. thumbnail Diagnostic and Interventional Cardiology: Medtronic Starts U.S. Launch of In.Pact Admiral Drug-Coated Balloon

    February 6, 2015

  3. thumbnail Vascular News: Medtronic reports US launch and first uses of IN.PACT Admiral drug-coated balloon

    Febuary 4, 2015

  4. thumbnail TCTMD: Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

    January 16, 2015

UC201600370a EN